Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical staging in multiple myeloma.

R K Woodruff, J Wadsworth, J S Malpas

    British Journal of Haematology
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Plasma and red blood cell concentrations of zinc, copper, selenium and magnesium in the first week of paediatric critical illness.

    Clinical nutrition (Edinburgh, Scotland)·2024
    Same author

    Transboundary movements of foot-and-mouth disease from India to Sri Lanka: A common pattern is shared by serotypes O and C.

    PloS one·2020
    Same author

    The evolution and phylodynamics of serotype A and SAT2 foot-and-mouth disease viruses in endemic regions of Africa.

    Scientific reports·2019
    Same author

    Are We All Oncologists?

    Journal of the Royal College of Physicians of London·2019
    Same author

    Correction: The phylogenetic analysis of VP1 genomic region in foot-and-mouth disease virus serotype O isolates in Sri Lanka reveals the existence of 'Srl-97', a newly named endemic lineage.

    PloS one·2018
    Same author

    The phylogenetic analysis of VP1 genomic region in foot-and-mouth disease virus serotype O isolates in Sri Lanka reveals the existence of 'Srl-97', a newly named endemic lineage.

    PloS one·2018

    The Durie and Salmon myeloma staging system effectively predicts patient survival. Higher tumor burden (Stage III) and renal impairment significantly correlate with shorter survival times in multiple myeloma patients.

    Area of Science:

    • Hematology
    • Oncology
    • Clinical Medicine

    Background:

    • Multiple myeloma is a hematologic malignancy characterized by uncontrolled plasma cell proliferation.
    • Accurate prognostication is crucial for effective treatment planning and clinical trial stratification.

    Purpose of the Study:

    • To evaluate the prognostic value of the Durie and Salmon staging system in a cohort of multiple myeloma patients.
    • To assess the impact of tumor cell mass and renal function on patient survival.

    Main Methods:

    • Retrospective analysis of 237 multiple myeloma patients.
    • Classification of patients into Stage I, II, and III based on the Durie and Salmon staging system.
    • Comparison of survival rates across different stages and in relation to renal function.

    Related Experiment Videos

    Main Results:

    • Significant differences in median survival were observed across stages: Stage I (64 months), Stage II (32 months), and Stage III (6 months) (P < 0.0001).
    • Patients with renal impairment had a significantly poorer median survival (2 months) compared to those with normal renal function (21 months) (P < 0.0001).

    Conclusions:

    • The Durie and Salmon staging system, incorporating tumor cell mass and protein synthesis rates, is a highly significant predictor of survival in multiple myeloma.
    • Renal function is a critical prognostic factor in multiple myeloma.
    • This staging system should be considered for future therapeutic trial designs in multiple myeloma.